about
Comparison of provider-documented and patient-reported brief intervention for unhealthy alcohol use in VA outpatients.Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs.Estimating risk of alcohol dependence using alcohol screening scores.Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgeryComparative performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders.Inconsistencies between alcohol screening results based on AUDIT-C scores and reported drinking on the AUDIT-C questions: prevalence in two US national samples.When quality indicators undermine quality: bias in a quality indicator of follow-up for alcohol misuse.An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health AdministrationUnhealthy alcohol use in older adults: Association with readmissions and emergency department use in the 30 days after hospital dischargeImplementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veteransComparison of DSM-IV and DSM-5 criteria for alcohol use disorders in VA primary care patients with frequent heavy drinking enrolled in a trial.Are Improvements in Measured Performance Driven by Better Treatment or "Denominator Management"?Changes in Patient-Reported Alcohol-Related Advice Following Veterans Health Administration Implementation of Brief Alcohol InterventionsVA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.Prevalence of clinically recognized alcohol and other substance use disorders among VA outpatients with unhealthy alcohol use identified by routine alcohol screening.Influence of a targeted performance measure for brief intervention on gender differences in receipt of brief intervention among patients with unhealthy alcohol use in the Veterans Health Administration.Variation in receipt of pharmacotherapy for alcohol use disorders across racial/ethnic groups: A national study in the U.S. Veterans Health Administration.Documented brief intervention not associated with resolution of unhealthy alcohol use one year later among VA patients living with HIV.Racial/Ethnic Differences in the Prevalence of Clinically Recognized Alcohol Use Disorders Among Patients from the U.S. Veterans Health Administration.Racial/ethnic differences in initiation of and engagement with addictions treatment among patients with alcohol use disorders in the veterans health administration.Variation in documented care for unhealthy alcohol consumption across race/ethnicity in the Department of Veterans Affairs Healthcare System.Alcohol screening scores and the risk of intensive care unit admission and hospital readmission.Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.Among patients with unhealthy alcohol use, those with HIV are less likely than those without to receive evidence-based alcohol-related care: A national VA study.Probability and predictors of patients converting from negative to positive screens for alcohol misuse.Decreasing sensitivity of clinical alcohol screening with the AUDIT-C after repeated negative screens in VA clinics.High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.Predictive Validity of Clinical AUDIT-C Alcohol Screening Scores and Changes in Scores for Three Objective Alcohol-related Outcomes in a Veterans Affairs (VA) Population.Follow-up care for alcohol misuse among OEF/OIF veterans with and without alcohol use disorders and posttraumatic stress disorder.Prevalence of alcohol misuse among men and women undergoing major noncardiac surgery in the Veterans Affairs health care system.Annual rescreening for alcohol misuse: diminishing returns for some patient subgroups.Postoperative risks associated with alcohol screening depend on documented drinking at the time of surgery.Extended release naltrexone for alcohol use disorders: quasi-experimental effects on mortality and subsequent detoxification episodes.The challenges of improving statistical practice in alcohol treatment research.A Research Agenda to Advance the Coordination of Care for General Medical and Substance Use Disorders.Possible Alternatives to Diagnosis-Based Denominators for Addiction Treatment Quality Measures.Prevalence of Alcohol Misuse and Follow-Up Care in a National Sample of OEF/OIF VA Patients With and Without TBI.Increased Rates of Documented Alcohol Counseling in Primary Care: More Counseling or Just More Documentation?AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers.AUDIT-C alcohol screening results and postoperative inpatient health care use.
P50
Q27312121-EF3A98A0-21D2-471A-8108-CD87B90CB585Q30401713-D8D47B2A-B595-4911-A690-7669214B9854Q30493558-4B6F4B47-C462-4445-AEAA-25D0182327A1Q30497875-3E46EF65-362D-4468-ABEE-5CC08BF0CF6FQ30525634-6C0FC321-BBF1-4E21-A8BE-EBA919822764Q30573639-8BFDD191-AAC9-4A3C-8EBF-3430165E0B9CQ30574361-8D071147-6E64-4ACF-A99F-DEAAB484BA0EQ30605503-E512C5E3-C586-4201-BE39-A301D6E2CAC9Q30710117-48687036-4415-45A6-87EB-0D5A2D94CD14Q33556410-348CF45E-A052-48B1-9B94-1A9D92B40A5AQ33912934-D9A12441-8289-4F06-859E-929EAB96D5B7Q36717504-E20F3D89-3D26-42CC-AE6B-9C2BB9E2CEEBQ36908796-DEE4FEBF-A4F5-41A8-B446-5D6340228B38Q37736801-2421D06B-9846-4B49-A55B-0A2ADBC31C88Q38173126-5D1652D7-FC3E-4A69-A720-B41DF1EDA9F3Q38605385-8EDF08C2-030A-42C4-8FAE-EB1EB353EF29Q38654314-96EAF1B8-E00B-41DF-9DAF-2F1BEF412A60Q38758283-55C7CBB0-27C2-440B-B05E-A8F967B305ECQ38912491-034D0C8B-70F3-4D98-B1B0-CE8D350D25E2Q39066051-E1F6039D-A4FA-4437-96CB-CDF8F8AB4AB9Q39642962-006122F6-32F1-4BAB-9559-09C8A5A0478BQ40145487-B1897FC1-4FFA-410F-BC49-3276A135EF5DQ40569141-A9BE0148-A3FD-4107-9315-3B369EF98BB8Q43489288-8E78C9D8-30C1-49C5-AA1E-D6BBF48DB467Q44873701-E7DC0283-8B97-4740-BEE4-931107CD2914Q45066391-6BFDD4D3-B45C-444F-ABA0-7CAE27261934Q45325851-25A7D78C-7A81-4307-BB18-AC46B6B39407Q45327417-25E9BE7A-D013-475B-A4DF-0E5BAE76457EQ45329372-947FAF6B-1419-4990-AB20-B390512F1D7BQ45330164-2121FCB7-7ECE-4021-A640-8E26B9DE37FEQ45787043-10FD040D-B3BD-4558-9CC8-37757FA2047DQ45876350-A386A956-19AE-4B58-8A70-2571D000526AQ45938302-12D5D862-20F9-42C0-B6B4-EB3A49557794Q45979815-D3B1D84C-2416-43CE-903D-246634E89AD1Q46405938-96CFFD45-525E-49CF-9E5B-E7D431DDE3F8Q46806018-A74B8390-43A3-4070-A1B2-377139A20FC1Q47153930-F5CA65EA-6D26-4E4C-8D8D-5719C396095DQ47734949-3123837B-A64C-4C13-85A9-D121581CC495Q48443347-611559ED-F8DE-44A3-B8DD-513F1B6A685AQ48758886-BB6D922F-E42E-4A12-A32A-D7C2D5882D60
P50
description
researcher ORCID ID = 0000-0002-8977-4779
@en
wetenschapper
@nl
name
Anna D Rubinsky
@ast
Anna D Rubinsky
@en
Anna D Rubinsky
@es
Anna D Rubinsky
@nl
type
label
Anna D Rubinsky
@ast
Anna D Rubinsky
@en
Anna D Rubinsky
@es
Anna D Rubinsky
@nl
prefLabel
Anna D Rubinsky
@ast
Anna D Rubinsky
@en
Anna D Rubinsky
@es
Anna D Rubinsky
@nl
P106
P1153
35235020400
P21
P31
P496
0000-0002-8977-4779